Clinical Trials Browser

Carcinoma, Non-Small-Cell Lung, Esophageal Neoplasms, Fallopian Tube Neoplasms, Lung Neoplasms, Melanoma, Multiple Myeloma, Ovarian Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Colorectal Neoplasms, Leukemia, Myeloid, Acute, Small Cell Lung Carcinoma, Triple Negative Breast Neoplasms

Clinical Trials

National Cancer Institute "Cancer Moonshot Biobank"

Analysis of the Clinical Experience With Rucaparib in the Rucaparib Access Program (RAP) in Spain - A GEICO Study

Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

HERO

GREAT

IMPrOVE

Prospective Cohort Study of Germline Variant Carriers With BRCA1 or BRCA2

Diet, Hepcidin, and Chemotherapy RDI

Collection of Malignant Ascites, Pleural Fluid, and Blood From People With Solid Tumors

Impact of Dietary Patterns on Prognosis of Ovarian Cancer Patients During PARPi Maintenance

Feasibility of Saliva and Remote Monitoring of Active Cytomegalovirus (CMV) Infection and Symptoms During Ovarian Cancer Treatment

Clonal Hematopoiesis and Therapy-Emergent Myeloid Neoplasms in Patients With Cancers, CHANCES Study

GYM-TASTE

ORACLE

START

BARHYSTER

Tempus Priority Study: A Pan-tumor Observational Study

Geriatric Assessment and Nursing Telephone Intervention in Elderly Women With Ovarian Cancer

A Post-marketing Surveillance to Assess the Safety and Effectiveness of Zirabev in Domestic Patients With Various Cancer

Specimen and Data Study for Ovarian Cancer Early Detection and Prevention

Mupet

Factors Influencing Cascade Testing Among Women With Hereditary Gynecological Cancers and Their Relatives

FOLL-OV

The Role of Cytomegalovirus and Inflammation on Patient Symptoms and Outcomes in Ovarian Cancer

Upfront Systematic Tumour BRCA Testing in Patients With High Grade Serous or Endometrioid Ovarian, Fallopian Tube or Primary Peritoneal Cancer (HGSEC): The t-BRCA Study

HALO

SUROVA

C-PATROL

Development and Management of Registry in Patients With Gynecologic Cancer in Korea

Determinants of Age-Related Treatment Effectiveness in Ovarian Cancer

BriTROC-2

Trial of Cytoreductive Surgery and HIPEC in Patients With Primary and Secondary Peritoneal Cancers

Structural and Functional Imaging and Cognitive Functions in Ovarian Cancer

Comprehensive Patient Questionnaires in Predicting Complications in Older Patients With Gynecologic Cancer Undergoing Surgery

Chemotherapy Toxicity On Quality of Life in Older Patients With Stage I, Stage II, Stage III, or Stage IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer

Niraparib as Maintenance Therapy in Patients With Platinum Sensitive Recurrent Ovarian Cancer

HORIZONS: Understanding the Impact of Cancer Diagnosis and Treatment on Everyday Life

nCYT

Evaluation of Robot-Assisted Surgery in Gynecologic Oncology

Incidence of Cancer in Women at Increased Genetic Risk of Ovarian Cancer

MIRRORS

Role of Spirituality in Coping and Surviving With Ovarian Cancer, Primary Peritoneal or Fallopian Tube Cancer

BRCA

Factors Associated With the Use of a High Volume Cancer Center by Black Women With Ovarian Cancer: A Qualitative Study

The Treatment Preferences of Women Diagnosed With Ovarian Cancer

OVATAR

Quality of Life and Care Needs of Patients With Persistent or Recurrent Ovarian Cancer, Fallopian Tube Cancer, or Peritoneal Cancer

Outcomes From Home in Patients Recovering From Major Gynecologic Cancer Surgery: Measuring Symptoms and Health-related Quality of Life

YKL-40 in Serum Samples From Patients With Newly Diagnosed Stage III-IV Ovarian Epithelial, Primary Peritoneal Cavity, or Fallopian Tube Cancer Receiving Chemotherapy

Biomarkers in Patients With Previously Untreated Invasive Ovarian Epithelial, Fallopian Tube, or Primary Peritoneal Cancer